Selenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon Cancers.
作者： Ahmed A. Abd-Rabou , Hanaa H. Ahmed , Aziza B. Shalby
DOI: 10.1007/S12011-019-01730-6
关键词:
摘要: Colon cancer in men and breast cancer in women are regarded as major health burdens, accounting for majority of cancer diagnoses globally. Doxorubicin (DOX) resistance in breast …
springer.com
sci-hub.se 参考文章(47)
Howard E. Ganther, Clement Ip, Yan Dong, Carleton Stewart, Identification of Molecular Targets Associated with Selenium-induced Growth Inhibition in Human Breast Cells Using cDNA Microarrays Cancer Research. ,vol. 62, pp. 708- 714 ,(2002)
Shanyuan Zheng, Xiaoling Li, Yibo Zhang, Qiang Xie, Yum-Shing Wong, Wenjie Zheng, Tianfeng Chen, PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction International Journal of Nanomedicine. ,vol. 7, pp. 3939- 3949 ,(2012) , 10.2147/IJN.S30940
Boryana Ruseva, Milena Atanasova, Reni Tsvetkova, Tatyana Betova, Margarita Mollova, Margarita Alexandrova, Pavlina Laleva, Aneliya Dimitrova, Effect of Selenium Supplementation on Redox Status of the Aortic Wall in Young Spontaneously Hypertensive Rats. Oxidative Medicine and Cellular Longevity. ,vol. 2015, pp. 609053- 609053 ,(2015) , 10.1155/2015/609053
Bo Yu, Xiaoling Li, Wenjie Zheng, Yanxian Feng, Yum-Shing Wong, Tianfeng Chen, pH-responsive cancer-targeted selenium nanoparticles: a transformable drug carrier with enhanced theranostic effects Journal of Materials Chemistry B. ,vol. 2, pp. 5409- 5418 ,(2014) , 10.1039/C4TB00399C
Merrill J. Christensen, Edward T. Nartey, Aimee L. Hada, Russell L. Legg, Brett R. Barzee, High Selenium Reduces NF-κB-Regulated Gene Expression in Uninduced Human Prostate Cancer Cells Nutrition and Cancer. ,vol. 58, pp. 197- 204 ,(2007) , 10.1080/01635580701328701
K Zu, T Bihani, A Lin, Y-M Park, K Mori, C Ip, Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene. ,vol. 25, pp. 546- 554 ,(2006) , 10.1038/SJ.ONC.1209071
Yue Wu, Ke Zu, Mary Ann Warren, Paul K. Wallace, Clement Ip, Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells. Molecular Cancer Therapeutics. ,vol. 5, pp. 246- 252 ,(2006) , 10.1158/1535-7163.MCT-05-0376
Fereshteh Ezzati Ghadi, Abdollah Ramzani Ghara, Shalmoli Bhattacharyya, Devinder Kumar Dhawan, Selenium as a chemopreventive agent in experimentally induced colon carcinogenesis World Journal of Gastrointestinal Oncology. ,vol. 1, pp. 74- 81 ,(2009) , 10.4251/WJGO.V1.I1.74
Ting Liu, Lilan Zeng, Wenting Jiang, Yuanting Fu, Wenjie Zheng, Tianfeng Chen, Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells Nanomedicine: Nanotechnology, Biology and Medicine. ,vol. 11, pp. 947- 958 ,(2015) , 10.1016/J.NANO.2015.01.009
Laura Smith, Mark B. Watson, Sara L. O'Kane, Philip J. Drew, Michael J. Lind, Lynn Cawkwell, The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Molecular Cancer Therapeutics. ,vol. 5, pp. 2115- 2120 ,(2006) , 10.1158/1535-7163.MCT-06-0190